Determining the Feasibility of MLN9708 as Maintenance After Allogeneic Stem Cell Transplant for Multiple Myeloma
Status:
Completed
Trial end date:
2019-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the safety of MLN9708 as maintenance therapy
following allogeneic stem cell transplant in patients with multiple myeloma.